O
LENZ

OrbiMed’s LENZ Therapeutics LENZ Stock Holding History

OrbiMed’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-121,202
Closed -$2.69K – 134
2022
Q3 		$2.69K Hold
121,202
– – 0.05% 118
2022
Q2 		$2.33K Sell
121,202
-102,485
-46% -$2.28M 0.04% 128
2022
Q1 		$7.99M Hold
223,687
– – 0.13% 107
2021
Q4 		$19.5M Buy
223,687
+16,558
+8% +$1.37M 0.25% 87
2021
Q3 		$23.8M Buy
207,129
+49,085
+31% +$7.27M 0.26% 87
2021
Q2 		$34M Buy
+158,044
New +$27.5M 0.34% 74

Other funds holding LENZ

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return